« Innovation Foundation Grant | Main | Participation in Bill & Melinda Gates Foundation Grant »

Initiation of Phase I Part B

MinervaX announces that it today has dosed the first subject in it Phase I Part B Dose-confirmation trial on its Group B Streptococcal vaccine GBS-NN, due to enrol 240 healthy adult women.